Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iveson

Showing results (541-550 of 573) with videos related to

Pageof 58
Sort By:
The Lancet. Oncology|February 5, 2020
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trialJohn A Bridgewater, Siân A Pugh, Tom Maishman, et al.
The Lancet. Digital Health|May 28, 2021
The challenges and opportunities of mental health data sharing in the UKTamsin Ford, Karen L Mansfield, Sarah Markham, et al.
British Journal of Cancer|July 20, 2016
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC studySiân A Pugh, Megan Bowers, Alexandre Ball, et al.
British Journal of Cancer|November 23, 2020
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancerPeter G Alexander, Antonia K Roseweir, Kathryn A F Pennel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety reportA F C Okines, R E Langley, L C Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2024
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG StudiesEnric Domingo, Caroline Kelly, Jennifer Hay, et al.
JAMA Oncology|October 2, 2025
The Definition of Cure in Colon Cancer: A Pooled Analysis of 15 Randomized Clinical TrialsAlessandro Pastorino, Heshan Liu, Levi Pederson, et al.
Journal of the National Cancer Institute|January 17, 2019
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal CancerVictoria Gray, Sarah Briggs, Claire Palles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2022
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant TrialsClaire Gallois, Qian Shi, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP StudyJohn Bridgewater, Peter Fletcher, Daniel H Palmer, et al.
Pageof 58

Showing results (541-550 of 573) with videos related to

Sort By:
Pageof 58
The Lancet. Oncology|February 5, 2020
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trialJohn A Bridgewater, Siân A Pugh, Tom Maishman, et al.
The Lancet. Digital Health|May 28, 2021
The challenges and opportunities of mental health data sharing in the UKTamsin Ford, Karen L Mansfield, Sarah Markham, et al.
British Journal of Cancer|July 20, 2016
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC studySiân A Pugh, Megan Bowers, Alexandre Ball, et al.
British Journal of Cancer|November 23, 2020
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancerPeter G Alexander, Antonia K Roseweir, Kathryn A F Pennel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety reportA F C Okines, R E Langley, L C Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2024
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG StudiesEnric Domingo, Caroline Kelly, Jennifer Hay, et al.
JAMA Oncology|October 2, 2025
The Definition of Cure in Colon Cancer: A Pooled Analysis of 15 Randomized Clinical TrialsAlessandro Pastorino, Heshan Liu, Levi Pederson, et al.
Journal of the National Cancer Institute|January 17, 2019
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal CancerVictoria Gray, Sarah Briggs, Claire Palles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2022
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant TrialsClaire Gallois, Qian Shi, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP StudyJohn Bridgewater, Peter Fletcher, Daniel H Palmer, et al.
Pageof 58